Commentary: Femoropopliteal In-Stent Restenosis: Gaining Ground With Excimer Laser and Drug-Coated Balloons

Abstract

Keywords

atherectomy balloon angioplasty drug-coated balloons excimer laser femoropopliteal segment in-stent restenosis laser atherectomy superficial femoral artery target lesion revascularization

Get full access to this article

View all access options for this article.

References

Schillinger

Sabeti

Loewe

et al . Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879–1888.

Laird

Katzen

Scheinert

et al . Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267–276.

Schillinger

Sabeti

Dick

et al . Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745–2749.

Laird

Katzen

Scheinert

et al . Nitinol stent implantation vs.balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012;19:1–9.

Shammas

Jones-Miller

Lemke

Meta-analysis-derived benchmarks of patency and target lesion revascularization of percutaneous balloon angioplasty from prospective clinical trials of symptomatic femoropopliteal in-stent restenosis. J Vasc Interv Radiol. 2016;27:1195–1203.

Dippel

Makam

Kovach

et al . Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv. 2015;8(1 Pt A):92–101.

Bosiers

Deloose

Callaert

et al . Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial. J Endovasc Ther. 2015;22:1–10.

Liistro

Angioli

Porto

et al . Paclitaxel-eluting balloon vs.standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther. 2014;21:1–8.

Krankenberg

Tübler

Ingwersen

et al . Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized Femoral Artery In-Stent Restenosis (FAIR) trial. Circulation. 2015;132:2230–2236.

10.

Brodmann

Keirse

Scheinert

et al ; IN.PACT Global Study Investigators. Drug-coated balloon treatment for femoropopliteal artery disease: the IN.PACT Global Study de novo in-stent restenosis imaging cohort. JACC Cardiovasc Interv. 2017;10:2113–2123.

11.

Thieme

Von Bilderling

Paetzel

et al ; Lutonix Global SFA Registry Investigators. The 24-month results of the Lutonix Global SFA Registry: worldwide experience with Lutonix drug-coated balloon. JACC Cardiovasc Interv. 2017;10:1682–1690.

12.

Kinstner

Lammer

Willfort-Ehringer

et al . Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial. JACC Cardiovasc Interv. 2016;9:1386–1392.

13.

Shammas

Hafez

et al . Safety and one-year revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med. 2012;13:341–344.

14.

Shammas

Helou

et al . Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med. 2012;13:224–227.

15.

Beschorner

Krankenberg

Scheinert

et al . Rotational and aspiration atherectomy for infrainguinal in-stent restenosis. Vasa. 2013;42:127–133.

16.

Shammas

Banerjee

et al . JetStream rotational and aspiration atherectomy in treating in-stent restenosis of the femoropopliteal arteries: results of the JETSTREAM-ISR feasibility study. J Endovasc Ther. 2016;23:339–346.

17.

Shammas

Arikat

et al . Five-year freedom from target-lesion revascularization using excimer laser ablation therapy in the treatment of in-stent restenosis of femoropopliteal arteries. J Invasive Cardiol. 2017;29:207–208.

18.

Grotti

Liistro

Angioli

et al . Paclitaxel-eluting balloon vs standard angioplasty to reduce restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: three-year results of the DEBATE-ISR study. J Endovasc Ther. 2016;23:52–57.

19.

Virga

Stabile

Biamino

et al . Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv. 2014;7:411–415.

20.

Kokkinidis

Hossain

Jawaid

et al . Laser atherectomy combined with drug-coated balloon angioplasty is associated with improved 1-year outcomes for treatment of femoropopliteal in-stent restenosis. J Endovasc Ther. 2018;25:xx–xx.

21.

van den Berg

Pedrotti

Canevascini

et al . In-stent restenosis: mid-term results of debulking using excimer laser and drug-eluting balloons: sustained benefit? J Invasive Cardiol. 2014;26:333–337.

22.

Sixt

Carpio Cancino

Treszl

et al . Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg. 2013;58:682–686.

23.

Gandini

Del Giudice

Merolla

et al . Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther. 2013;20:805–814.

24.

Rosenfield

Jaff

White

et al . Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373:145–153.

25.

Tepe

Laird

Schneider

et al . Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131:495–502.

26.

Tosaka

Soga

Iida

et al . Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59:16–23.

27.

Zeller

Dake

Tepe

et al . Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. JACC Cardiovasc Interv. 2013;6:274–281.

28.

Stabile

Virga

Salemme

et al . Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol. 2012;60:1739–1742.